Envestnet Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,630
Closed -$15.2K 4324
2024
Q1
$15.2K Hold
21,630
﹤0.01% 4148
2023
Q4
$37.9K Sell
21,630
-48
-0.2% -$70 ﹤0.01% 3999
2023
Q3
$31.2K Hold
21,678
﹤0.01% 3961
2023
Q2
$56.4K Hold
21,678
﹤0.01% 3865
2023
Q1
$79.8K Hold
21,678
﹤0.01% 3818
2022
Q4
$38.4K Sell
21,678
-150
-0.7% -$399 ﹤0.01% 3888
2022
Q3
$86K Buy
+21,828
New +$134K ﹤0.01% 3762

Other funds holding DMTK

Envestnet Asset Management's DMTK Position: Q2 2024 in Review

Envestnet Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 21,630 shares — an estimated $15.2K sold.

Envestnet Asset Management first reported a position in DMTK in Q3 2022 and held it in 7 quarters. The position peaked at $86K in Q3 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Envestnet Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 21,630 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $15.2K.
  • Envestnet Asset Management first reported a position in DermTech, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Envestnet Asset Management's DermTech, Inc. Common Stock position peaked at $86K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Envestnet Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.